Dr. Scott Clinton McFerren Jr., MD

Dr. McFerren practices at Texas Health Plano in Plano, Texas, part of Texas Health Resources.

Dr. McFerren's NPI, 1396108098, was assigned on March 30, 2016. Dr. McFerren graduated from LSU Health Shreveport School of Medicine in 2016. Dr. McFerren holds Texas license T2008.

Dr. McFerren's primary practice is Texas Health Plano, at 6200 W Parker Rd, Plano, TX 75093 in Collin County. The practice phone is (972) 981-8000.

Dr. McFerren's primary practice is Texas Health Plano in Plano, Texas, part of Texas Health Resources. Dr. McFerren is also affiliated with Baylor Scott & White Medical Center - Plano. The medical group on file is Urology Clinics of North Texas. Dmand AI also links Dr. McFerren to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McFerren practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. McFerren's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. McFerren is board certified in urology by the American Board of Urology. Dmand AI has Dr. McFerren's licenses on file in 2 states: Texas and New Mexico.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. McFerren treats.

CMS data shows 3,377 Medicare services from Dr. McFerren across 26 procedure codes in 2024, for 481 Medicare patients. Medicare paid $138,198 for them.

CMS counts 481 Medicare patients who saw Dr. McFerren in 2024. The largest group is 65 to 74, with 217 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McFerren's median patient age at 64, with 23% women.

In 2024, Dr. McFerren wrote 1,699 Medicare Part D claims for 394 patients. 88% of them were for generic drugs. CMS names the drug for 1,600 of them, across 33 drugs with 11 or more claims each, at $445,263 in total drug cost. In 2023, CMS named 963 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. McFerren for performance year 2024, reported as part of a group. Dr. McFerren accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McFerren as offering telehealth. CMS counts 15 procedures of prostate resection by Dr. McFerren, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. McFerren, published from 2018 to 2019. Dr. McFerren's most frequent co-authors are Gena Colleen Dunivan, MD and Tessa E. Krantz, MD.

CMS Open Payments shows 254 general payments to Dr. McFerren from 46 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 81% of the total. Boston Scientific Corporation paid the most, $2,488.

Dr. McFerren graduated from LSU Health Shreveport School of Medicine in 2016.

Dr. McFerren is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.